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Deﬁcient Wnt signalling triggers striatal synaptic
degeneration and impaired motor behaviour in
adult mice
Soledad Galli1, Douglas M. Lopes1, Rachida Ammari2, Jaakko Kopra3, Sarah E. Millar4,
Alasdair Gibb2 & Patricia C. Salinas1
Synapse degeneration is an early and invariant feature of neurodegenerative diseases. Indeed,
synapse loss occurs prior to neuronal degeneration and correlates with the symptom severity
of these diseases. However, the molecular mechanisms that trigger synaptic loss remain
poorly understood. Here we demonstrate that deﬁcient Wnt signalling elicits synaptic
degeneration in the adult striatum. Inducible expression of the secreted Wnt antagonist
Dickkopf1 (Dkk1) in adult mice (iDkk1) decreases the number of cortico-striatal glutamatergic
synapses and of D1 and D2 dopamine receptor clusters. Synapse loss occurs in the absence
of axon retraction or cell death. The remaining excitatory terminals contain fewer synaptic
vesicles and have a reduced probability of evoked transmitter release. IDkk1 mice show
impaired motor coordination and are irresponsive to amphetamine. These studies identify
Wnts as key endogenous regulators of synaptic maintenance and suggest that dysfunction in
Wnt signalling contributes to synaptic degeneration at early stages in neurodegenerative
diseases.
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A
proper balance between synapse formation, maintenance
and elimination is essential for normal brain function.
Although the molecular mechanisms that regulate
synapse formation and growth have been well documented1–4,
little is known about how synaptic stability is regulated in the
adult brain. Notably, several neurodegenerative diseases exhibit
early loss of synapses, with neuronal degeneration only occurring
at later stages5–8. Indeed, early synapse loss often occurs
concomitantly with the manifestation of the characteristic
symptoms of these diseases6,7,9. In addition, several studies
suggest that synapse loss leads to axon retraction and the
subsequent death of neurons10,11. Therefore, understanding the
molecular mechanisms that trigger synaptic degeneration is
critical for developing therapeutic approaches to ameliorate the
symptoms and prevent neuronal death in neurodegenerative
diseases.
In Parkinson’s and Huntington’s disease (PD and HD), loss of
synapses in the striatum results in deﬁcits in glutamatergic and
dopaminergic transmission5,6. In the striatum, the medium spiny
neurons (MSNs), which represents 95% of all striatal neurons6,12,
receive glutamatergic inputs from the cerebral cortex and the
thalamus12,13. MSNs also receive dopaminergic inputs from the
substantia nigra, which modulate glutamatergic transmission6,12.
Interestingly, several proteins linked to PD and HD, such as
a-synuclein (a-syn), Parkin and Huntingtin, play important roles
in synaptic function5,11,14,15. Indeed, PD and HD animal models
based on loss or gain of function of these genes reveal synaptic
dysfunction and impaired striatal-regulated behaviour before or
in the absence of neuronal death9,16–20. These studies support the
notion that synapse loss and dysfunction occur at early stages of
the disease and account for the striatal-mediated behavioural
deﬁcit. However, the molecular mechanisms that lead to synaptic
degeneration in PD and HD remain poorly understood.
Recent studies suggest that Wnt signalling could play a role in
synaptic maintenance in the adult brain21. Wnts are a family of
secreted glycoproteins that promote synaptogenesis and regulate
synaptic function in both vertebrates and invertebrates1–4.
Indeed, we have shown that blockade of Wnt signalling by the
Wnt antagonist Dickkopf1 (Dkk1) promotes shrinkage and
disassembly of excitatory synapses in mature hippocampal
neurons without affecting cell viability21. In acute hippocampal
slices, amyloid-b oligomers, a key pathogenic protein in
Alzheimer’s disease, increase the level of Dkk1 and promote the
disassembly of synapses. Importantly, amyloid-b-induced
synaptic degeneration is suppressed by blockade of Dkk1 with
speciﬁc anti-Dkk1 antibodies21. These ﬁndings indicate that
deﬁcient endogenous Wnt signalling could contribute to synaptic
degeneration in neurodegenerative diseases. However, the role of
Wnts in the stability of synapses in vivo remains unexplored.
Here we investigated whether dysfunction of Wnt signalling
in vivo triggers synaptic degeneration in the adult striatum, an
area increasingly studied for its crucial function in motor
coordination, executive function and working memory. To
bypass the requirement of Wnts during embryonic and postnatal
development, we established an inducible transgenic mouse
model that expresses Dkk1, an effective and speciﬁc Wnt
antagonist that blocks Wnt signalling by interfering with the
Wnt co-receptor LRP6 (refs 22,23). Inducible expression of Dkk1
in the adult striatum triggers the degeneration of cortico-striatal
glutamatergic synapses and the disassembly of D1 and D2
dopamine receptor (D1R and D2R) clusters, without causing
axon retraction or cell death. Electrophysiological recordings
demonstrate an impaired cortico-striatal glutamatergic synaptic
transmission. Importantly, Wnt blockade with Dkk1 results in
poor motor coordination and an inability to respond
to psychostimulants such as amphetamine, both classical
striatal-regulated behaviours. Together, these studies identify
endogenous Wnt signalling as a key regulator of synaptic
maintenance/stability in the adult striatum. Our ﬁndings also
suggest that deﬁciency in Wnt signalling could contribute to
neurodegenerative diseases such as PD and HD where striatal
synapses are compromised early in the disease. Moreover, we
introduce the iDkk1 transgenic mice as a model system to
investigate the mechanisms that control synaptic stability at early
stages of midbrain-associated neurodegenerative diseases.
Results
Wnt signalling components are expressed in the striatum. To
address the potential role of Wnt signalling in the striatum, we
ﬁrst evaluated the expression of Wnts, their receptors and
antagonists. We examined the expression of Wnt components in
the striatum of adult mice (3 months of age) and comparatively
during synaptogenesis (P15 mice, the peak of synaptogenesis)24,
by reverse transcriptase (RT)-PCR. We found that several Wnts
are expressed at both stages and Wnt2, Wnt3, Wnt5a and Wnt7b
are the most highly expressed Wnt genes in the adult striatum
(Supplementary Fig. 1). Several Wnt receptors such as Frizzled-3
(Fz3), Fz6, Fz8 and Fz9 and the co-receptor LRP6 are expressed
both in P15 and adult striatum (Supplementary Fig. 1). Wnt
antagonists such as the secreted-frizzled-related proteins (Sfrps)
1–5 and Dickkopf 3 are also expressed in both stages
(Supplementary Fig. 1). These results demonstrate that several
Wnts, their receptors and modulators are expressed during
synapse development and in the adult striatum.
Inducible expression of Dkk1 in the dorsal striatum. To
determine whether deﬁcient Wnt signalling triggers synaptic
degeneration in the adult striatum, we established a transgenic
mouse model where the activity of several Wnts is blocked in the
adult brain. As Wnt signalling is crucial during early embryonic
patterning and morphogenesis25,26, it was essential to develop a
system where Wnt signalling was unaffected during embryonic
and postnatal development. To this aim, we generated an
inducible transgenic line that expresses Dkk1, a speciﬁc and
effective secreted Wnt antagonist22,23, upon administration of
Figure 1 | Inducible expression of Dkk1 in the striatum of adult mice blocks canonical Wnt signalling without causing cell death. (a) Scheme of
doxycycline-induced Dkk1 expression. CaMKIIa-rtTA transgenic mice are crossed to tetO-Dkk1 transgenic mice. Double-transgenic offspring (iDkk1)
are fed with doxycycline to induce Dkk1 expression. (b) RT–PCR showing Dkk1 expression in the striatum of adult mice after doxycycline feeding. (c) In situ
hybridization of Dkk1 in mice after 14 days of doxycycline feeding. Top left, scheme of a sagittal section indicating the area shown at high magniﬁcation.
Scale bar, 100mm. (d) Cleaved-caspase 3 immunostaining. Top right, panoramic of a coronal slice labelled with vGlut1 depicting the striatum (St).
Scale bar, 200 mm. Left, high-magniﬁcation images of area indicated in the white box. Scale bar, 100mm. Positive control, acute cortical slices from P2 mice
labelled with cleaved-caspase 3 and Hoechst. (e) Apoptosis evaluation by TUNEL assay. Higher-magniﬁcation images of the dorsal striatum (St) and
corpus callosum (CC). Brain slices treated with DNAse I were used as positive controls. Scale bar, 100mm. (f) b-catenin levels. Top, a panoramic
of a sagittal section labelled with vGlut1. Scale bar, 200mm. Below, high-magniﬁcation images obtained from the dorsal striatum (white box). Scale bar,
5 mm. Error bars represent s.e.m., *P¼0.045, one-way ANOVA with replication, 9–12 images from 4 slices from each mouse and 4 mice per condition
were analysed.
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doxycycline during adulthood. In the absence of Dkk1, Wnts bind
to Fz receptors and the co-receptor LRP6 resulting in stabilization
of b-catenin, which translocates to the nucleus and activates gene
transcription27. In contrast, Dkk1 blocks the binding of Wnts to
Fz/LRP6, resulting in b-catenin phosphorylation and degradation
by the proteasome pathway26,27. As Dkk1 is not expressed in the
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adult brain, inducible expression of Dkk1 in the adult provides a
powerful and highly speciﬁc approach to examine the
contribution of Wnt signalling to synaptic stability and function.
We used the tetracycline-inducible system, in which expression
of Dkk1 is induced by administration of doxycycline during
adult stages. Mice carrying the Dkk1 coding region under the
control of a doxycycline-responsive promoter (tetO)28 were
crossed to mice carrying the doxycycline-controlled transactivator
(rtTA) downstream of the CaMKIIa promoter29. Dkk1
expression is induced in double-transgenic animals (iDkk1
hereafter) by addition of doxycycline into the diet when
animals reach adulthood (Fig. 1a). CaMKIIa is highly expressed
in striatal MSNs30,31 and indeed, the CaMKIIa-rtTA system can
effectively drive gene expression under the tetO system in the
striatum29,32,33.
To induce expression of Dkk1, iDkk1 mice (3–6 months old,
adult mice hereafter) were fed with doxycycline for different
periods of time. In all experiments, a combination of wild-type
(wt) or single-transgenic mice (CaMKII-rtTA or tetO-Dkk1) were
fed with doxycycline and used as controls. Expression of Dkk1 is
detected by RT-PCR only in iDkk1 mice fed with doxycycline, but
not in single-transgenic mice fed with doxycycline, or in iDkk1
mice not fed with doxycycline (Fig. 1b). Dkk1 expression is
detected after 3 days of doxycycline exposure and is sustained as
long as animals are fed with doxycycline (Fig. 1b). We next
examined the expression of Dkk1 in the striatum by in situ
hybridization. Indeed, Dkk1 messenger RNAs are detected in
striatal cells of iDkk1 mice but not in single-transgenic littermates
after 14 days of feeding with doxycycline, or in iDkk1 mice using
a Dkk1 sense probe (Fig. 1c). The pattern is consistent with the
expression driven by CaMKIIa promoter in MSNs29. Given that
Dkk1 speciﬁcally blocks canonical Wnt signalling, these
transgenic mice provide a model system to investigate the role
of this signalling pathway in synaptic stability and function in the
adult brain.
Dkk1 blocks canonical Wnt signalling without cell death.
IDkk1 mice not exposed to doxycycline develop normally and
have no overt sensory motor defects based on their ability to
move normally. To study the impact of Wnt blockade in the adult
brain, Dkk1 expression was induced for 2 weeks (hereafter), as
this period is required for full induction of the CaMKII-rtTA/
tetO system with doxycycline33. By visual inspection, we found
that induction of Dkk1 expression does not affect the overall
morphology of the brain. To further characterize these mice, we
examined possible changes in cell viability as several studies have
shown that increased Dkk1 levels are correlated with increased
neuronal death in models of epilepsy, ischaemia and Alzheimer’s
disease34–36. However, the level of cell death is not affected in the
adult striatum of iDkk1 mice, as determined by the level of
activated caspase 3 and by the terminal deoxynucleotidyl
transferase dUTP nick end labelling (TUNEL) assay (Fig. 1d,e).
As CaMKII-rtTA can also drive the expression of Dkk1 in the
somatosensory cortex29, we evaluated cell death in cortical areas
by the TUNEL assay and by labelling with activated caspase 3.
However, we observed no changes in cell death in the
somatosensory cortex of iDkk1 mice when compared with
controls (Supplementary Fig. 2). In addition, no difference in
the total number of striatal and cortical neurons, labelled with the
speciﬁc marker NeuN, or in the total number of striatal and
cortical cells (labelled with the nuclear marker Hoechst) was
observed in iDkk1 mice when compared with controls
(Supplementary Fig. 3). Together, these ﬁndings demonstrate
that induction of Dkk1 expression for 2 weeks does not affect cell
viability or the overall structure of the brain.
Dkk1 is a well-established Wnt antagonist that speciﬁcally
blocks the canonical Wnt pathway22,23, resulting in increased
b-catenin phosphorylation and degradation26,27. We therefore
examined the levels of b-catenin in iDkk1 mice. We found that
some b-catenin puncta colocalize with the pre- or postsynaptic
terminal of excitatory synapses, labelled by the speciﬁc
presynaptic marker vGlut1 or the postsynaptic marker
PSD95 (B10% colocalization), and also with nuclei (B3%
colocalization). However, most of the b-catenin puncta are
located to other structures (Supplementary Fig. 4). Thus,
b-catenin puncta are present in different cell compartments in
the striatum. As expected, when we analysed the iDkk1 mice, we
found a signiﬁcant decrease of b-catenin puncta (B30% decrease,
Fig. 1f). Given the low level of colocalization of b-catenin to
synapses, these ﬁndings indicate that the decrease in b-catenin
puncta mainly occurs outside synapses. These ﬁndings show that
canonical Wnt signalling is compromised in iDkk1 mice.
Dkk1 triggers degeneration of cortico-striatal synapses. Our
previous studies using mature hippocampal neurons demon-
strated that blockade of Wnt signalling with Dkk1 induces the
rapid disassembly of synapses in mature cultured hippocampal
neurons21. Therefore, we proposed that Wnt signalling plays a
role in synapse maintenance in the adult brain. Here, we
examined whether deﬁcient Wnt signalling in the adult striatum
leads to synaptic degeneration.
Striatal MSNs receive glutamatergic input from cortex and
thalamus12, which can be distinguished by the differential
expression of vGlut1 or vGlut2 in the presynaptic terminal of
cortical or thalamic inputs, respectively13,37. We ﬁrst assessed the
effect on cortico-striatal excitatory synapses by evaluating the
colocalization of vGlut1 and the postsynaptic marker PSD95.
Although we measured a decrease in the number of PSD95
puncta following Dkk1 induction, this was not statistically
signiﬁcant (Fig. 2). However, Dkk1 expression signiﬁcantly
decreases the volume and number of vGlut1 puncta, as well as
the colocalization of vGlut1 with PSD95 (B30% decrease, Fig. 2).
Thus, blockade of Wnt signalling in the adult striatum results in
degeneration of cortico-striatal glutamatergic synapses.
We next evaluated whether blockade of Wnt signalling affects
thalamo-striatal glutamatergic synapses by examining the colo-
calization of vGlut2 and PSD95. In contrast to vGlut1, induction
of Dkk1 in the striatum does not signiﬁcantly affect the volume or
number of vGlut2 puncta or the number of colocalized vGlut2-
and PSD95-labelled synapses (Fig. 3). Together these ﬁndings
demonstrate that Dkk1 speciﬁcally affects the maintenance of
cortico- but not thalamo-striatal synapses in the adult striatum.
To further evaluate the effect of Dkk1 on glutamatergic
synapses, we analysed synapses at the ultrastructural level. Using
electron microscopy (EM) we observed a decrease in the number
of asymmetric synapses, that is, glutamatergic synapses, in the
striatum of adult iDkk1 mice (B17% decrease, Supplementary
Fig. 5). This decrease is smaller to that observed by the
colocalization of vGlut1 with PSD95 (30% decrease of cortico-
striatal glutamatergic synapses). This difference could be
explained by the fact that Dkk1 preferentially affects cortico-
striatal but not thalamo-striatal glutamatergic synapses,
which represent B50% of glutamatergic striatal synapses13.
Taken together, these results demonstrate that endogenous Wnt
signalling is crucial for the maintenance of speciﬁc glutamatergic
synapses in the striatum.
To investigate functional changes in excitatory synaptic
function, we recorded miniature excitatory postsynaptic currents
(mEPSCs) and spontaneous postsynaptic currents (sEPSCs) in
striatal MSNs. Induction of Dkk1 expression does not affect the
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frequency or amplitude of mEPSCs or sEPSCs (Fig. 4). These
results are unexpected, given the overall decrease in the
glutamatergic input in adult iDkk1 mice (B17% as detected by
EM, Supplementary Fig. 5). Our interpretation is that the overall
decrease in the number of excitatory synapses is not sufﬁcient to
signiﬁcantly change mEPSCs and sEPSCs, although there is a
signiﬁcant decrease in the number of excitatory cortico-striatal
synapses.
Dkk1 impairs presynaptic structure and function. Our EM
analyses and colocalization of pre- and postsynaptic markers
demonstrate that a number of excitatory synapses are refractory
to dysfunction in Wnt signalling. To investigate the potential
effect of Dkk1 on the remaining synapses, we examined the pre-
and postsynaptic ultrastructure. We observed that blockade of
Wnt signalling in iDkk1 mice decreases the number of vesicles at
the active zone (Fig. 5a). In contrast, no signiﬁcant changes in the
PSD length and width, or synaptic cleft width are observed
(Fig. 5b), consistent with our confocal immunoﬂuorescence
analyses where the number and size of PSD95-labelled puncta are
unaffected in iDkk1 mice (Fig. 2). No changes in the number of
dendritic spines in MSNs of adult iDkk1 mice are observed by
Golgi staining (Fig. 5c). Together these ﬁndings demonstrate that
Dkk1 affects predominantly the presynaptic side of excitatory
synapses.
In light of these ﬁndings, we investigated whether transmitter
release was affected by recording EPSCs in MSNs. Evoked
responses were obtained by stimulation of cortico-striatal
afferents using a paired-pulse stimulation protocol. We found
that the EPSC paired-pulse ratio (PPR) in iDkk1 mice is higher
than in control mice, consistent with a decrease in release
probability (Fig. 5d). Altogether these results demonstrate that
deﬁcient Wnt signalling in the adult striatum induces structural
and functional defects at cortico-striatal presynaptic terminals.
Dkk1 triggers degeneration of dopamine synapses. The dopa-
minergic input from the substantia nigra is an important
regulator of glutamatergic transmission in striatal synapses. We
therefore examined the dopaminergic synapses in the dorsal
striatum of iDkk1 mice. We ﬁrst determined the levels of dopa-
mine and its derivatives, 3,4-dihydroxyphenylacetic acid and
homovanillic acid using high-performance liquid chromato-
graphy in the adult striatum of iDkk1 exposed to doxycycline. We
found that dopamine levels are not affected (Fig. 6a). In addition,
no signiﬁcant changes in other neurotransmitters such as ser-
otonin (5-HT) and its metabolite 5-hydroxyindoleacetic acid
levels were detected in iDkk1 mice (Fig. 6a).
Next, we examined whether the input from dopamine cells
into the striatum was altered in adult iDkk1 mice. The total
intensity of tyroxine hydroxylase (TH)- or vesicular monoamine
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transporter 2 (VMAT2)-positive processes is unchanged (Fig. 6b),
indicating that Dkk1 does not affect dopaminergic axons or the
dopamine content of these axons.
To investigate possible changes in the sensitivity of MSNs to
dopamine, we analysed the D1 and D2 dopamine receptors (D1R
and D2R). Total levels of TH, dopamine transporter (DAT) and
D1R and D2R proteins are not affected in iDkk1 mice, as
determined by western blot analyses (Fig. 6c). Interestingly,
blockade of Wnt signalling signiﬁcantly reduces the volume and
number of D1R and D2R puncta (Fig. 6d). Altogether these
results suggest that deﬁcient Wnt signalling causes the disas-
sembly of dopamine receptor puncta without affecting the total
protein levels. This effect could be due to decreased clustering
and/or receptor trafﬁcking, changes in the rate of internalization
or due to dispersal of the receptors.
Striatal synaptic degeneration impairs motor coordination.
Given the signiﬁcant defect in the cortico-striatal glutamatergic
and dopaminergic synapses in the striatum of iDkk1 mice, we
evaluated whether the striatum-regulated behaviour was affected.
IDkk1 mice do not exhibit defects in the open-ﬁeld task indi-
cating that general sensorimotor activity, exploratory and anxi-
ety-like behaviour are normal (data not shown). In addition, mice
move normally suggesting no defects in cerebellar function. We
next examined motor coordination and learning using the
rotarod, a reliable motor-learning task that provides information
about dorsal striatal function during different phases of learn-
ing38. Indeed, disruption of dorsal striatal synaptic plasticity and
function leads to impairments in motor learning in the
rotarod38,39. IDkk1 mice exhibit impaired motor performance,
as the latency to fall is signiﬁcantly reduced compared with
controls (Fig. 7a). IDkk1 and control mice exhibit a similar
between-session improvement (Fig. 7a), suggesting that iDkk1
animals are able to learn. However, iDkk1 mice show motor
impairment initially and after training on the rotarod (Fig. 7a),
indicating that performance, but not task learning, is impaired in
Dkk1-expressing mice.
D1R loss impairs amphetamine-induced locomotion. As iDkk1
mice exhibit the loss of D1R clusters in the dorsal striatum, we
evaluated whether these mice show impaired locomotion. Eva-
luation of non-habituated control and iDkk1 animals for a period
of 45min revealed no signiﬁcant difference in total locomotion
(Fig. 7b), indicating that iDkk1 mice show similar spontaneous
locomotion to control littermates.
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Stimulation of dopamine signalling by psychostimulants such
as amphetamine or cocaine causes an increase in locomotion
through D1Rs40–43. As Wnt blockade induces degeneration of
D1R clusters, we predicted that the response to amphetamine
would be impaired in iDkk1 mice. As previously reported,
amphetamine (2mg kg 1) signiﬁcantly increases locomotion in
control animals when compared with saline-injected mice
(Fig. 7c). In contrast, amphetamine does not increase
locomotion in iDkk1 mice compared with iDkk1 mice injected
with saline (Fig. 7c). Although iDkk1 mice are slightly hyperactive
compared with controls when injected with saline, this difference
is not statistically signiﬁcant (Fig. 7c). As iDkk1 mice exhibit
similar dopamine, VMAT2 and DAT levels to control mice
(Fig. 6a–c), the lack of response to amphetamine is likely due to
defects in the stability of postsynaptic D1R clusters. These
ﬁndings indicate that blockade of Wnt signalling impairs the
locomotion in response to increased dopamine release.
Discussion
Here we report a novel role for Wnt signalling in the
maintenance/stability of excitatory and dopaminergic synapses
in the adult striatum. We demonstrate that in vivo blockade of
Wnt signalling by inducibly expressing the secreted Wnt
antagonist Dkk1, results in a signiﬁcant degeneration of
dopaminergic and cortico-striatal excitatory synapses in the adult
striatum and a decrease in glutamate release from cortico-striatal
afferents. Importantly, these synaptic defects correlate with
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impairment in striatal-regulated function. Our studies shed new
light into the signalling pathways that control synaptic main-
tenance in the adult striatum.
Induction of Dkk1 expression in the adult striatum blocks Wnt
signalling without affecting cell viability. Speciﬁc induction of
Dkk1 expression for a period of 2 weeks in adult iDkk1 transgenic
mice show a decrease in the number of b-catenin puncta in the
dorsal striatum, indicating that Dkk1 indeed blocks the canonical
Wnt signalling pathway26,27. Previous studies suggest that
increased Dkk1 levels may contribute to cell loss after cerebral
ischaemia, epilepsy and in neurodegenerative diseases34–36.
However, we have previously shown that Dkk1 does not affect
cell viability in mature hippocampal neurons21. Consistent with
this study, we demonstrate here that induction of Dkk1 expression
does not induce cell loss in the adult striatum or in the
somatosensory cortex (an area that innervates the striatum).
Moreover, we observed neither dopaminergic axon retraction nor
changes in dopamine levels and its metabolites in the striatum,
suggesting that the viability of the dopaminergic neurons in the
substantia nigra is unaffected by striatal expression of Dkk1. These
ﬁndings strongly support our conclusion that induction of Dkk1
in the adult striatum does not trigger neuronal degeneration.
Endogenous Wnt signalling is required for synaptic integrity in
the adult striatum. Although a role for Wnt signalling in synapse
formation and function has been well established, its contribution
to synaptic stability in the adult brain has remained unexplored.
Here we demonstrate that endogenous Wnts are required for the
integrity of glutamatergic cortico-striatal synapses and stability of
D1R and D2R clusters in the adult striatum. Interestingly,
glutamatergic inputs from the thalamus are unaffected in iDkk1
mice, suggesting that blockade of Wnt signalling induces the
disassembly of speciﬁc synapses.
Blockade of canonical Wnt signalling in the adult induces
presynaptic structural and functional changes at excitatory
synapses. Importantly, Dkk1 mice exhibit a signiﬁcant increase
in PPR indicative of reduced probability of release accompanied
with a reduced number of vesicles at the ultrastructural level.
Thus, deﬁciency in Wnt signalling causes a signiﬁcant disruption
of cortico-striatal transmission by affecting presynaptic function.
Wnt deﬁciency in the striatum results in impaired locomotion
characteristic of striatal dysfunction. IDkk1 mice exhibit deﬁcits
in motor coordination in the rotarod test as observed in D1R and
D2R null mice or after pharmacological inhibition of these
receptors38,44. Interestingly, both D1R and D2R are necessary for
motor coordination during the learning stages of the task,
whereas only D2R is important for motor performance once the
task becomes a habit38. IDkk1 mice exhibit impaired motor
coordination during learning and after 4 days of training,
suggesting that initial impairment in coordination may be due
to the decrease in both D1R and D2R clusters, whereas impaired
performance observed once the task is learnt could be due to the
decreased number of D2R clusters. In addition, iDkk1 mice are
irresponsive to amphetamine, a psychostimulant that increases
extracellular dopamine levels through blockade of dopamine
uptake, increased dopamine release from intracellular stores and
the reversal of the DAT42,43. This defect is likely to be due to the
decreased number of D1R puncta rather than to a presynaptic
defect, as neither dopaminergic axon retraction nor changes in
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dopamine levels are observed in the striatum of iDkk1 mice.
These ﬁndings highlight the importance of endogenous Wnt
signalling in dopaminergic transmission at striatal neurons.
Loss of synapses is an early event in several neurodegenerative
diseases, including PD and HD5,6. Indeed, PD and HD mouse
models exhibit signiﬁcant deﬁcits in glutamatergic and
dopaminergic neurotransmission and motor defects before or in
the absence of neuronal degeneration8,9,16–20. Similarly, iDkk1
mice exhibit deﬁcits in glutamatergic and dopaminergic
transmission that correlate with impaired striatal-mediated
behaviour. Although these changes occur in the absence of
neuronal degeneration, the phenotype of iDkk1 mice has striking
similarities to those observed in PD and HD genetic models.
Although a genetic link between dysfunction in Wnt signalling
and PD has not been reported, a key component of the Wnt
signalling pathway, Dishevelled (Dvl), has been recently shown to
interact with LRRK2, the most prevalent and dominant mutation
in PD45. In addition, Vps35, an essential retromer subunit that is
linked to autosomal dominant late-onset PD46, regulates Wnt
secretion47,48. These studies suggest that deﬁcient Wnt signalling
could contribute to the pathogenesis of PD during the early stages.
In conclusion, the iDkk1 mice recapitulate the early stages of
neurodegenerative diseases when synapses are compromised.
Here, we introduce iDkk1 mice as a model system to elucidate
the molecular mechanisms that lead to synaptic degeneration and
dysfunction in the absence of neuronal death.
Methods
In vivo induction of Dkk1 expression in the adult striatum. All experiments were
performed in accordance with the Animals Scientiﬁc procedures Act UK (1986).
Heterozygous tetO-Dkk1 transgenic mice28 were crossed with the heterozygous
CaMKIIa-rtTA mice29 to obtain the double-transgenic animals (iDkk1). The mice
background was C57BL/6J. Genotypes were conﬁrmed by PCR using DNA
isolated from ear notches. For CaMKIIa-rtTA, the primers used were forward
50-TGCCTTTCTCTCCACAGGTGTCC-30 , reverse 50-GAGAGCACAGCGGAA
TGAC-30 ; for tetO-Dkk1, forward 50-GCGTCCTTCGGAGATGATGG-30 , reverse
50-AAATGGCTGTGGTCAGAGGG-30 .
IDkk1 and control mice were administered food supplemented with 6mg kg 1
doxycycline (Datesand group) for 14 days unless otherwise indicated. Doxycycline-
fed wt and single-transgenic animals were used as controls. Experiments were
performed in 3–6-month-old mice. Both male and female mice were used for
cellular biology experiments. For behavioural and electrophysiological experiments
only males were used.
RT-PCR analysis of gene expression. RNA was extracted from the striatum of
three P15 and three adult mice (3 months old) using Trizol (Invitrogen) and
treated with DNAse I (Sigma). First, strand complementary DNA synthesis was
performed with AMV Reverse Transcriptase (Promega) according to the manu-
facturer’s instruction. PCR was performed using GoTaq Polymerase (Promega).
The primers used are indicated in Supplementary Table 1.
In situ hybridization. Brains of iDkk1 or control mice were snap-frozen in iso-
pentane cooled in liquid nitrogen and stored at  80 C. Twelve mm sagittal sec-
tions were cut in a cryostat, air dried and ﬁxed in 4% paraformaldehyde (PFA) in
phosphate-buffered saline (PBS) prior to labelling49. Probes50 were labelled with
digoxigenin using the DIG RNA labelling kit (Invitrogen) according to the
manufacturer’s instructions.
Immunohistochemistry. IDkk1 and control mice were anaesthetized, decapitated
and brains rapidly dissected and ﬁxed overnight in 4% PFA at 4 C. The brains
were next washed with PBS, immersed in 30% sucrose/PBS and frozen in iso-
pentane or OCT in dry ice. Twenty-mm-thick cryosections were collected onto
slides (Superfrost Plus–VWR) and stored at  20 C.
TUNEL staining was performed with ApoptoTag Red In Situ Apoptosis
detection kit (Chemicon International) according to the manufacturer’s
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instructions. Positive controls were obtained by digesting brain sections with
DNAse I 1 mgml 1 in 30mM Tris buffer, 4mM MgCl2, 0.1mM dithiothreitol, pH
7.4 for 10min at room temperature (RT).
To detect apoptosis using cleaved-caspase 3 staining, brain slices were blocked
in 10% donkey serum, 0.02% Triton X-100 in PBS for B4 h at RT and then
incubated with a primary antibody anti-cleaved-caspase 3 (Cell Signaling, 1:500)
overnight at 4 C and a secondary antibody conjugated with Alexa 568 (Invitrogen)
for 2 h. Finally, brain sections were incubated with Hoescht for 5min and mounted
in Fluoromount-G. As a positive control, horizontal acute brain slices of cortex
from P2 mice were incubated at 37 C for a period of 4 h and then stained as above.
For dopaminergic synapses, brain sections were blocked and incubated with
primary and secondary antibodies as described above. Primary antibodies were
D1R (Sigma, 1:200), D2R (Millipore, 1:500), VMAT2 (Acris, 1:1,000) and TH
(Millipore, 1:1,000). Secondary antibodies conjugated with Alexa 488, Alexa 568
and Alexa 647 were from Invitrogen (dilution 1:800).
Acute brain slices and staining of glutamatergic synapses. Brains were rapidly
dissected and placed into ice-cold artiﬁcial cerebro-spinal ﬂuid in mM: 150 NaCl, 3
KCl, 2 CaCl2, 1.25 NaH2PO4, 26 NaHCO3, 10 D-glucose, pH 7.4. Sagittal slices
(200–300 mm) were cut at 4 C with a vibratome (Campden Instruments) and ﬁxed
in 4% PFA/4% sucrose in PBS for 20–30min at RT. Sections were subsequently
washed with PBS and blocked in 10% donkey serum, 0.02% Triton X-100 in PBS
for B4 h at RT. Primary antibodies against vGlut1 (Millipore, 1:1,000), vGlut2
(Millipore, 1:1,000), PSD95 (Thermo Scientiﬁc, 1:500) and b-catenin (BD trans-
duction labs, 1:1,000) were incubated overnight at 4 C. Secondary antibodies were
as described above. Slices were washed in PBS and mounted in Fluoromount-G
(SouthernBiotech).
Confocal microscopy. Confocal images were acquired in an Olympus FV1000,
Leica SP1 or Leica DMRE confocal microscopes using a 60 1.35 numerical
aperture (NA) oil objective or 63 1.40 NA oil objective for Olympus and Leica
microscopes, respectively. Image stacks of 8 equidistant planes (B200 nm) of
76 nm per pixel 76 nm per pixel were taken for each ﬁeld. Analysis was per-
formed using Volocity software (Perkin Elmer). Synaptic and b-catenin puncta
volume and number as well as VMAT2 and TH volume and intensity were
quantiﬁed using custom Volocity protocols with standard thresholding techniques,
and punctum density was normalized to the volume of the imaged ﬁeld.
To quantify synaptic puncta and synapses, we ﬁrst selected puncta using a
threshold over the total ﬂuorescence intensity of the image. Selected puncta were
those with a ﬂuorescence intensityo40% of the total image ﬂuorescence intensity
(the percentage of intensity used for thresholding varied according to the
ﬂuorophore used, from 20 to 50%). Second, when two or more puncta were
identiﬁed as one, they were separated into individual puncta using a custom
protocol in Volocity (‘separate touching objects’) with a puncta size guide of
0.5 mm. Synapses were determined when vGlut1 or vGlut2 puncta overlapped with
PSD puncta in 41 pixel. Finally, the number, the volume and the mean
ﬂuorescence intensity of the puncta were measured.
To quantify the total ﬂuorescence intensity of TH and VMAT, axons were
selected when the ﬂuorescence intensity of TH or VMAT was 440% of the total
ﬂuorescence intensity of the image. Total and mean ﬂuorescence intensity was
quantiﬁed within these selected areas.
Quantiﬁcation of monoamines and their metabolites. The concentration of
dopamine, 3,4-dihydroxyphenylacetic acid, homovanillic acid, serotonin (5-HT)
and 5-hydroxyindolacetic acid (5-HIAA) were analysed from the striatum of iDkk1
and control mice, using HPLC with electrochemical detection51. Brain samples
were homogenized in six parts of 0.2M HClO4 and one part of antioxidant solution
containing oxalic acid combined with acetic acid and L-cysteine. The homogenates
were centrifuged at 20,800 g for 35min at 4 C. The supernatant (350 ml) was
transferred to a 0.5-ml Vivaspin ﬁlter concentrator (10,000 MWCO PES; Sartorius
Stedim, Goettingen, Germany) and centrifuged at 8,600 g for 35min at 4 C.
Filtrate containing monoamines was analysed using a Gemini 3-mm column (C18,
110Å, 75 4.6mm; Phenomenex, USA) kept at 45 C with a heater (Croco-Cil,
Bordeaux, France). The mobile phase consisted of 0.1M NaH2PO4 buffer,
150mg l 1 of octane sulphonic acid, 5% methanol and 450mg l 1 EDTA, pH 3.0
using H3PO4. Pump (ESA Model 582 Solvent Delivery Module; ESA, Chelmsford,
MA) equipped with a pulse damper (SSI LP-21, Scientiﬁc Systems, State College,
PA) provided a 1mlmin 1 ﬂow rate. Hundred microlitres of ﬁltrate was injected
into the chromatographic system with a Shimadzu/SIL-20AC autoinjector
(Shimadzu, Kyoto, Japan). Monoamines and their metabolites were detected using
ESA CoulArray Electrode Array Detector, and chromatograms were processed and
concentrations of monoamines calculated using CoulArray1 for windows software
(ESA). Monoamine and metabolite values were calculated as nanograms per gram
(ng g 1) wet weight of tissue.
Golgi staining and spine quantiﬁcation. Brains were removed and immersed in
Golgi solution (FD Rapid GolgiStain Kit, FD Neuro Technologies) for 7 days.
Impregnation steps were performed according to the manufacturer’s instructions.
The specimens were frozen and cut on a Leica CM3050 cryostat. Serial sagittal
sections of 100 mm thickness were collected on slides (Superfrost Plus–VWR) and
left to dry in the dark at RT for 48 h. Staining was done as suggested by the
manufacturer. Slides were dehydrated in graded ethanol, cleared with xylene and
mounted with Permount (TAAB Laboratories). Single-plane images were captured
on an Olympus BX60 wide-ﬁeld microscope with a 100 1.3 NA oil objective and
analysed with Volocity software. Spines, deﬁned as dendritic protrusions with a
deﬁnable head, were counted manually on stretches of secondary or tertiary den-
drites and normalized to dendrite length.
EM. Brains of iDkk1 or control mice ﬁxed with 4% PFA, 0.5% glutaraldehyde in
0.1M Milloning phosphate buffer, pH 7.4 overnight at 4 C were cut into coronal
sections (200 mm thickness) on a vibratome and postﬁxed in 1% osmium tetroxide
in cacodylate buffer for 1 h. Slices were then stained in aqueous uranyl acetate for
45min, dehydrated in graded alcohol and embedded in resin. Ultrathin sections
(70 nm) of silver–gold interference colour were cut and collected on a 200-mesh-
grid52. Electron micrographs were acquired using a JEOL1010 electron microscope
at a magniﬁcation of  40,000 or  60,000 in the dorsal striatum just below the
corpus callosum. Asymmetric synapses were evaluated only when a clear pre- and
postsynaptic membrane was visualized, with the presence of a prominent PSD
density in the postsynaptic and vesicles in the presynaptic site53,54. PSD length and
synaptic cleft length were quantiﬁed by visual placement of a line tool across the
maximum head (for spines) or the longest axis. Vesicles were counted within
200 nm of the active zone.
Western blotting. Homogenates prepared from striatum of iDkk1 or control mice
(n¼ 4) were run on SDS–polyacrylamide gel electrophoresis, and western blots
were probed with antibodies against DAT (Millipore), a-tubulin (Sigma) and the
TH (1:1,000), D1R (1:500) and D2R (1:500) mentioned above. Band intensity was
quantiﬁed using ImageJ software (NIH). Protein content was normalized against a-
tubulin (1:1,000). Full blots can be found in Supplementary Fig. 6.
Rotarod. Mice fed for 8–13 days were placed on a rotarod (Med associates)
accelerating from 4–40 r.p.m. in 3min and the latency to fall was recorded. Mice
received ﬁve consecutive trials per session, one session per day for 4 days. Max-
imum trial length was 5min, after which the animals were returned to the cage.
Rest between trials was B30 s (ref. 55).
Spontaneous locomotion. Naive animals fed with doxycycline for 14–21 days
were placed in 44 44-cm polycarbonate cages with opaque walls for 45min.
Locomotion was recorded from a camera placed above the cages and analysed with
Daqtrack video tracking software (Axona).
Amphetamine-induced locomotion. Motor activity was recorded in 8 identical
activity monitor chambers consisting of transparent boxes (43 43 cm) equipped
with 16 infrared light emitters and detectors (Med Associates). These were con-
nected to a computer that counts the number of times the photobeams are broken
(as the animal crosses between the emitter and the detector). The total number of
horizontal beam breaks was used as a measure of locomotion. Mice fed with
doxycycline for 14–21 days were individually placed in the activity chamber and
habituated for 1 h prior to the experiment. After habituation, mice were admi-
nistered amphetamine (D-amphetamine sulphate, Sigma, 2mg kg 1 in saline) or
saline intraperitoneally. Locomotor activity was monitored for 1 h immediately
after the injection by registering the infrared photobeam interruptions.
Electrophysiology. Brains were quickly removed and placed in an oxygenated ice-
cold solution containing (in mM): 100 sucrose, 25 glucose, 75 NaCl, 25 NaHCO3, 1
CaCl2, 4 MgCl2, 2.5 KCl, 1.25 NaH2PO4.2H2O, 0.25 kynurenic acid, 2 pyruvic acid
and 0.1 EDTA. Sagittal brain slices (300 mm) were transferred to an incubating
chamber containing (in mM): 125 NaCl, 26 NaHCO3, 2.5 KCl, 1.26 NaH2-
PO4.2H2O, 25 glucose, 1 MgCl2 and 1 CaCl2 oxygenated with 95% O2-5% CO2.
After a 1-h recovery period, slices were visualized under the microscope with
infrared Nomarski differential interference contrast optics (Axioskop FS; Zeiss). All
recordings were made at RT. Whole-cell voltage clamp recordings were obtained
from dorsal striatal MSNs identiﬁed by morphological and electrophysiological
criteria (cell size, membrane capacitance and cell response to depolarizing current
injection). The sEPSCs were recorded in the presence of 10 mM bicuculline, a
selective GABAA receptor antagonist. mEPSCs were recorded in the presence of
10 mM bicuculline and 100 nM TTX. Recordings were performed at  70mV
holding potential using glass pipettes, pulled from standard borosilicate glass
capillaries ﬁlled with a pipette solution containing (in mM): 139 D-gluconic acid
lactone, 10 HEPES, 10 EGTA, 10 NaCl, 0.5 CaCl2, 1 MgCl2, 1 ATP and 0.5 GTP
adjusted to pH 7.2 with CsOH. Currents were recorded using an Axopatch 200A
Ampliﬁer, ﬁltered at 1 kHz and digitized in the computer at 10KHz. The data were
acquired with Win EDR and analysed using Win EDR and WinWCP (freely
available at http://spider.science.strath.ac.uk/sipbs/software_ses.htm).
To evaluate the PPR, MSNs afferents were electrically stimulated using a bipolar
concentric stimulating electrode placed in the anterior portion of the deep layers of
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the motor cortex, at the level of the white matter between the cortex and the
striatum. Paired-pulse stimulation was performed to record evoked synaptic
currents (eEPSCs). This was performed by giving 2 consecutive pulses separated by
50ms every 10 s up to 20 times. The ratio (PPR) of the second evoked current to
the ﬁrst was compared between wt and iDkk1 mice. Differences in the intensity of
stimulation required to obtain a given synaptic event were not observed across
genotypes (range: 8–30V, 0.05ms pulse duration).
Statistical analyses. For all set of samples, normality and homogeneity of var-
iance were conﬁrmed by Lilliefords and w2-tests, respectively. If samples showed a
normal distribution and homogeneity of variance, parametric tests were applied as
described below. Otherwise, samples were analysed by a non-parametric test.
b-catenin puncta were analysed by one-way analysis of variance (ANOVA) with
blocking and replication. Mice were considered as blocks. For each mouse, 9–12
ﬁelds were imaged from 4 different slices and four mice were used for each
condition. No statistical signiﬁcance was observed between mice.
Synaptic puncta and colocalization of synaptic markers were analysed by one-
way ANOVA with blocking and replication. The number of experiments was
considered as blocks; typically three independent experiments, each of them with
1–3 mice from each condition. A minimum of 15 images were obtained from 3
different slices per mice.
TH and VMAT total ﬂuorescence intensity were analysed by non-parametric
Kruskal–Wallis ANOVA, as normality could not be conﬁrmed for control samples.
Three images were imaged and analysed per slice, 3–4 slices per mouse, six mice
per condition.
The number of asymmetric synapses was analysed in EM micrographs by non-
parametric Kruskal–Wallis ANOVA. Eighteen to twenty images from each mouse,
4 mice for each condition were analysed. The number of vesicles was analysed by
one-way ANOVA with blocking and replication. Mice were considered as blocks.
Vesicles were counted in 17–25 synapses from each control mouse and 15–19
synapses from each iDkk1 mouse, four mice were used for each condition. No
statistical signiﬁcance was observed between mice. For the analysis of PSD length
and width and cleft width, data were pooled and analysed by non-parametric
Kruskal–Wallis ANOVA. More than 140 synapses obtained from 4 different mice
per condition were analysed.
Number of spines in Golgi-stained images was analysed by non-parametric
Kruskal–Wallis ANOVA. Nine–50 dendrite stretches obtained from 4 different
mice per condition were analysed.
The content of dopamine and other metabolites in the striatum was analysed by
the Student’s t-test in 10 control mice and 7 iDkk1 mice.
Western blot data were analysed by non-parametric Kruskal–Wallis ANOVA in
four mice for each condition.
PPR was analysed using the unpaired t-test, 14 cells from control and 18 cells
from iDkk1 mice were evaluated. mEPSCs and sEPSCs were analysed by the
Student’s t-test, 20 and 27 neurons were recorded from control and iDkk1 mice for
mEPSCs, respectively, and, 16 and 17 neurons from control and iDkk1 mice for
sEPSCs, respectively.
Spontaneous locomotion was evaluated by the Student’s t-test and ANOVA for
repeated measures, eight mice for each condition. Amphetamine-induced
locomotion was evaluated by two-way ANOVA, 8 controls with saline, 8 controls
with amphetamine, 9 iDkk1 with saline and 11 iDkk1 with amphetamine. Rotarod
data were evaluated by ANOVA for repeated measures, 12 control and 19 iDkk1
mice were used.
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